|
|
|
Volumn 9, Issue 50, 2000, Pages 180-181
|
|
Pregnancy and mefloquine prevention of malaria
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHLOROQUINE;
MEFLOQUINE;
PROGUANIL;
ARTICLE;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONGENITAL MALFORMATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG EXPOSURE;
DRUG MEGADOSE;
DRUG RESISTANCE;
FEMALE;
FRANCE;
HUMAN;
MAJOR CLINICAL STUDY;
MALARIA;
MALARIA CONTROL;
NONHUMAN;
PREGNANCY;
PREGNANCY TERMINATION;
PROSPECTIVE STUDY;
RISK;
RISK BENEFIT ANALYSIS;
SECOND TRIMESTER PREGNANCY;
TERATOGENICITY;
THIRD TRIMESTER PREGNANCY;
TREATMENT INDICATION;
WORLD HEALTH ORGANIZATION;
ABNORMALITIES, DRUG-INDUCED;
ANIMALS;
ANTIMALARIALS;
CLINICAL TRIALS;
COHORT STUDIES;
FEMALE;
HUMANS;
INFANT, NEWBORN;
MALARIA;
MEFLOQUINE;
MICE;
PREGNANCY;
PREGNANCY OUTCOME;
RATS;
TREATMENT OUTCOME;
|
|
EID: 0034456307
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (19)
|
